Mridu Gulati

4.9k total citations · 1 hit paper
53 papers, 2.2k citations indexed

About

Mridu Gulati is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Mridu Gulati has authored 53 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 16 papers in Physiology and 10 papers in Molecular Biology. Recurrent topics in Mridu Gulati's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (31 papers), Sarcoidosis and Beryllium Toxicity Research (15 papers) and Occupational and environmental lung diseases (10 papers). Mridu Gulati is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (31 papers), Sarcoidosis and Beryllium Toxicity Research (15 papers) and Occupational and environmental lung diseases (10 papers). Mridu Gulati collaborates with scholars based in United States, China and Canada. Mridu Gulati's co-authors include Erica L. Herzog, Lynne A. Murray, Jack A. Elias, Xueyan Peng, Robert Homer, Thomas Russell, Michael S. Kramer, Rochelle L. Argentieri, Cory M. Hogaboam and David P. Hesson and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Mridu Gulati

49 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Persistent Exertional Intolerance After COVID-19

2021 197 citations Mridu Gulati et al. CHEST Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mridu Gulati United States	24	1.2k	480	342	332	241	53	2.2k
Debashish Danda India	29	1.2k 1.0×	418 0.9×	627 1.8×	340 1.0×	145 0.6×	180	3.1k
Alessandra Majorana Italy	30	461 0.4×	338 0.7×	373 1.1×	596 1.8×	240 1.0×	90	2.8k
Richard Hewitt United Kingdom	24	899 0.8×	461 1.0×	321 0.9×	218 0.7×	79 0.3×	89	2.3k
Vedat Hamuryudan Türkiye	39	2.2k 1.9×	518 1.1×	302 0.9×	243 0.7×	105 0.4×	153	5.7k
Jonathan A. Kropski United States	30	2.3k 2.0×	732 1.5×	232 0.7×	457 1.4×	345 1.4×	67	3.4k
Ying Gao China	29	432 0.4×	691 1.4×	293 0.9×	352 1.1×	117 0.5×	136	2.3k
Riccardo Melicòni Italy	33	973 0.8×	448 0.9×	593 1.7×	277 0.8×	71 0.3×	137	3.5k
Göran Tornling Sweden	29	1.1k 0.9×	764 1.6×	239 0.7×	577 1.7×	307 1.3×	106	2.8k
Antônio Sérgio Petrilli Brazil	27	752 0.6×	606 1.3×	162 0.5×	90 0.3×	297 1.2×	121	2.4k
Ioannis Kalomenidis Greece	25	1.2k 1.1×	304 0.6×	262 0.8×	214 0.6×	52 0.2×	97	2.1k

Countries citing papers authored by Mridu Gulati

Since Specialization

Citations

This map shows the geographic impact of Mridu Gulati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mridu Gulati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mridu Gulati more than expected).

Fields of papers citing papers by Mridu Gulati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mridu Gulati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mridu Gulati. The network helps show where Mridu Gulati may publish in the future.

Co-authorship network of co-authors of Mridu Gulati

This figure shows the co-authorship network connecting the top 25 collaborators of Mridu Gulati. A scholar is included among the top collaborators of Mridu Gulati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mridu Gulati. Mridu Gulati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adams, Traci N., Carrie A. Redlich, Craig S. Glazer, & Mridu Gulati. (2025). Hypersensitivity pneumonitis associated with home mold exposure: A retrospective cohort analysis. PLoS ONE. 20(5). e0323093–e0323093. 1 indexed citations

Oldham, Justin M., Megan L. Neely, Daniel Wojdyla, et al.. (2025). Changes in Lung Function and Mortality Risk in Patients With Idiopathic Pulmonary Fibrosis. CHEST Journal. 168(2). 415–422. 1 indexed citations

Sack, Coralynn, Daniel Wojdyla, Amanda J. Gassett, et al.. (2024). Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry. Annals of the American Thoracic Society. 22(3). 378–386. 5 indexed citations

Damsky, William, Alice Wang, Daniel Kim, et al.. (2022). Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nature Communications. 13(1). 3140–3140. 62 indexed citations

Patel, Divya, et al.. (2022). Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study. BMJ Open Respiratory Research. 9(1). e001254–e001254. 3 indexed citations

Gao, Ruijuan, Xueyan Peng, Huanxing Sun, et al.. (2021). Macrophage-derived netrin-1 drives adrenergic nerve–associated lung fibrosis. Journal of Clinical Investigation. 131(1). 43 indexed citations

Minasyan, Maksym, Lokesh Sharma, Wei Liu, et al.. (2021). Elevated IL-15 concentrations in the sarcoidosis lung are independent of granuloma burden and disease phenotypes. American Journal of Physiology-Lung Cellular and Molecular Physiology. 320(6). L1137–L1146. 5 indexed citations

Case, Amy Hajari, Anne S. Hellkamp, Megan L. Neely, et al.. (2020). Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry. Annals of the American Thoracic Society. 17(6). 699–705. 18 indexed citations

Culver, Daniel A., Jürgen Behr, John A. Belperio, et al.. (2019). Patient Registries in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 200(2). 160–167. 26 indexed citations

10.

Ryu, Changwan, Taylor Adams, Buqu Hu, et al.. (2019). Plasma mitochondrial DNA is associated with extrapulmonary sarcoidosis. European Respiratory Journal. 54(2). 1801762–1801762. 8 indexed citations

11.

Todd, Jamie L., Megan L. Neely, Robert Overton, et al.. (2019). Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry. Respiratory Research. 20(1). 227–227. 60 indexed citations

12.

Snyder, Laurie D., Megan L. Neely, Anne S. Hellkamp, et al.. (2019). Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry. Respiratory Research. 20(1). 105–105. 50 indexed citations

13.

Cullinan, Paul, Xavier Muñoz, Hille Suojalehto, et al.. (2017). Occupational lung diseases: from old and novel exposures to effective preventive strategies. The Lancet Respiratory Medicine. 5(5). 445–455. 101 indexed citations

14.

Reilkoff, Ronald A., Hong Peng, Lynne A. Murray, et al.. (2012). Semaphorin 7a+ Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1–induced Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 187(2). 180–188. 97 indexed citations

15.

Redlich, Carrie A., Paul D. Blanc, Mridu Gulati, & Ware G. Kuschner. (2012). Preface. Clinics in Chest Medicine. 33(4). xi–xii. 1 indexed citations

16.

Sauler, Maor & Mridu Gulati. (2012). Newly Recognized Occupational and Environmental Causes of Chronic Terminal Airways and Parenchymal Lung Disease. Clinics in Chest Medicine. 33(4). 667–680. 24 indexed citations

17.

Lee, Chun Geun, Erica L. Herzog, Farida Ahangari, et al.. (2012). Chitinase 1 Is a Biomarker for and Therapeutic Target in Scleroderma-Associated Interstitial Lung Disease That Augments TGF-β1 Signaling. The Journal of Immunology. 189(5). 2635–2644. 73 indexed citations

18.

Gulati, Mridu. (2011). Diagnostic assessment of patients with interstitial lung disease. Primary Care Respiratory Journal. 20(2). 120–127. 23 indexed citations

19.

Murray, Lynne A., Rogério Silva Rosada, Ana Paula Moreira, et al.. (2010). Serum Amyloid P Therapeutically Attenuates Murine Bleomycin-Induced Pulmonary Fibrosis via Its Effects on Macrophages. PLoS ONE. 5(3). e9683–e9683. 160 indexed citations

20.

Gulati, Mridu, Martin D. Slade, Martha Fiellin, & Mark R. Cullen. (2009). Healthcare for Obstructive Lung Disease in an Industrial Spirometry Surveillance Program. Journal of Occupational and Environmental Medicine. 51(3). 336–342. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact